Major cable and broadcast news outlets seem to have largely ignored a Wall Street Journal report that Donald Trump Jr. stands to potentially benefit financially from a deal between BlinkRx and the government-run TrumpRx pharmaceutical program. Apparently, neither The New York Times or The Washington Post covered the Journal’s findings either.
The big news outlets are getting real quiet, real fast.
Two words explain why: Brendan Carr.
Any broadcast that upsets Trump’s grift, is going to get a lot of heat from FCC Chairman and Trump stooge, Brendan Carr.